RTU_1096



NAME OF DRUG : RTU_1096

ALSO KNOWN AS : RTU_1096

LABORATORY : SUCAMPO

STATUS AND ADVANCEMENT

Type of drug : Vap-1 inhibitor

Clinical trials advancement : Ongoing Phase 1

Estimated time to market : 128 months.

LABORATORY ABSTRACT ON THE DRUG

NOT PROVIDED

RECENT NEWS ON RTU_1096

SOME PUBLICATIONS RELATED WITH RTU_1096

SOME NASHBIOTECHS POINTS OF VIEW RELATED WITH RTU_1096


WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE